Therapy with preferential and specific COX-2 inhibitors;Therapie mit präferentiellen und spezifischen COX-2-inhibitoren

Internist

Volumn 42, Issue 3, 2001, Pages 421-426

  Stichtenoth, D O ^a   Frolich J C ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR;

ENZYME INHIBITION; GERMANY; HUMAN; REVIEW; RHEUMATIC DISEASE; TREATMENT INDICATION;

ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; HUMANS; ISOENZYMES; LACTONES; MEMBRANE PROTEINS; PAIN; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; RANDOMIZED CONTROLLED TRIALS; SULFONAMIDES; SULFONES; THIAZINES; THIAZOLES;

EID: 0035107163     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001080050769     Document Type: Review

References (32)

1. Non-steroid anti-inflammatory drugs and life threatening complications of peptic ulceration
2. Avoidance of renal side effects of NSAIDs: Value of selective COX-2
3. Death attributed to antirheumatic medication in a nationwide series of 1666 patients with rheumatoid arthritis who have died
4. Recent considerations in non-steroidal anti-inflammatory drug gastropathy
5. Anti-inflammatory drugs and their mechanism of action
6. Towards a better aspirin
7. Selective COX-2 inhibitors: Is the water becoming muddy?
8. Basic biology and clinical application of specific cyclooxygenase-2 inhibitors
9. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2
10. A classification of NSAIDs according to the relative inhibition of cyclooxygenase isozymes
11. The classification of cyclooxygenase inhibitors
12. Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man
13. Neue nicht-steroidale antirheumatika: Selektive hemmstoffe der induzierbaren cyclooxygenase
14. Salsalate cross-sensitivity in aspirin-sensitive patients with asthma
15. Effects of meloxicam and indomethacin on cyclooxygenase pathways in healthy volunteers
16. Safety of meloxicam: A global analysis of clinical trials
17. Efficacy and tolerability of meloxicam in an observational, controlled cohort study in patients with rheumatic disease
18. An open study to assess the safety and tolerability of meloxicam 15 mg in subjects with rheumatic disease and mild renal impairment
19. Effect of selective inhibition of the inducible cyclooxygenase on renin release in healthy volunteers
20. Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: A randomized, controlled trial
21. Pharmacokinetics. COX-2 specifity, and tolerability of supratherapeutic doses of rofecoxib in humans
22. Analysis of the effect of COX-2 specific inhibitors and recommendations for their use in cliniccal practice
23. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis
24. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs
25. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis - The Class study: A randomized controlled trial
26. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
27. Effects of celecoxib and naproxen on renal function in the elderly
28. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids
29. Are selective COX-2 inhibitors nephrotoxic?
30. Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low salt diet. A randomized, controlled trial
31. COX-1-sparing NSAIDs - Is the enthusiasm justified?